JP2004503233A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503233A5
JP2004503233A5 JP2002510516A JP2002510516A JP2004503233A5 JP 2004503233 A5 JP2004503233 A5 JP 2004503233A5 JP 2002510516 A JP2002510516 A JP 2002510516A JP 2002510516 A JP2002510516 A JP 2002510516A JP 2004503233 A5 JP2004503233 A5 JP 2004503233A5
Authority
JP
Japan
Prior art keywords
den
protein
residues
sequence
ectodomain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002510516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503233A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2001/001570 external-priority patent/WO2001096376A2/en
Publication of JP2004503233A publication Critical patent/JP2004503233A/ja
Publication of JP2004503233A5 publication Critical patent/JP2004503233A5/ja
Pending legal-status Critical Current

Links

Images

JP2002510516A 2000-06-16 2001-06-18 デング熱ウイルスエンベロープ糖タンパク質のプロ−アポトーシスフラグメント Pending JP2004503233A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21212900P 2000-06-16 2000-06-16
PCT/IB2001/001570 WO2001096376A2 (en) 2000-06-16 2001-06-18 Pro-apoptotic fragments of the dengue virus envelope glycoproteins

Publications (2)

Publication Number Publication Date
JP2004503233A JP2004503233A (ja) 2004-02-05
JP2004503233A5 true JP2004503233A5 (cg-RX-API-DMAC7.html) 2005-02-03

Family

ID=22789669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510516A Pending JP2004503233A (ja) 2000-06-16 2001-06-18 デング熱ウイルスエンベロープ糖タンパク質のプロ−アポトーシスフラグメント

Country Status (6)

Country Link
US (2) US6673895B2 (cg-RX-API-DMAC7.html)
EP (1) EP1311539A2 (cg-RX-API-DMAC7.html)
JP (1) JP2004503233A (cg-RX-API-DMAC7.html)
AU (1) AU2001282388A1 (cg-RX-API-DMAC7.html)
CA (1) CA2412257A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001096376A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002211490A1 (en) * 2000-10-04 2002-04-15 The Trustees Of The University Of Pennsylvania Compositions and methods of using capsid protein from flaviviruses and pestiviruses
US7189403B2 (en) * 2003-06-30 2007-03-13 Institut Pasteur Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
CA2508266A1 (fr) 2005-06-20 2006-12-20 Institut Pasteur Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae
DK1939214T3 (da) 2006-12-22 2013-10-14 Pasteur Institut Celler og metodik til at generere ikke-segmenterede negativstrengede RNA-vira

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136561A (en) * 1995-05-24 2000-10-24 Hawaii Biotechnology Group, Inc. Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems
CA2290090A1 (fr) * 1999-12-07 2001-06-07 Marie-Pierre Courageot Lignee cellulaire stable inductible n2aprm+e incluant l'adnc codant pour les glycoproteines prm et e du virus den-1: un systeme modele pour tester les proprietes inhibitrices des agents anti-viraux cibles pour les glycoproteines de l'enveloppe des flaviviridae

Similar Documents

Publication Publication Date Title
Hüssy et al. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase
Suzich et al. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes
Ryan et al. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing
JP4504464B2 (ja) キメラフラビウイルスワクチン
ES2664505T3 (es) Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
Mizushima et al. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2
JP2002510494A5 (cg-RX-API-DMAC7.html)
WO2002089731A3 (en) Agents for treatment of hcv and methods of use
DE69534600D1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
Totsuka et al. Hepatitis A virus proteins
US20050053624A1 (en) West nile virus vaccine
JPH10511556A (ja) Ｈｃｖ ｎｓ３プロテアーゼのタンパク質分解活性を有するポリぺプチドを製造し、精製し、分析する方法
US5830691A (en) Method of producing ectoprotein of hepatitis C virus
JP3045778B2 (ja) Ｃ型肝炎ウイルスプロテアーゼの不溶性凝集物をリフォールディングするための方法
EP0518313A2 (en) Gene of hepatitis C virus or fragment thereof, polypeptide encoded by the same
Yasumasa et al. Processing of hepatitis C viral polyprotein in Escherichia coli
US6022685A (en) Methods and compositions for detecting anti-hepatitis E virus activity
BG105065A (en) A vaccine-induced hepatitis b viral strain and uses thereof
ATE424409T1 (de) Chimere human papilloma virus 16 l1 proteine, welche ein l2 peptid enthalten, damit hergestellte virus-ähnliche partikel und methode zur herstellung der partikel
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
Lorenzo et al. Expression and immunological evaluation of the Escherichia coli‐derived hepatitis C virus envelope E1 protein
Dueñas‐Carrera et al. Immunization with a DNA vaccine encoding the hepatitis‐C‐virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (crab‐eating macaque monkeys)
GR3015437T3 (en) Non-a non-b sequences.
Dueñas‐Carrera et al. Immunological evaluation of Escherichia coli‐derived hepatitis C virus second envelope protein (E2) variants